Key facts
- Active LCDs
- 204
- Contracts
- 7
- 15004, 15101, 15102, 15201, 15202, 17013, 18003
- States and territories
- 37
- AL AR CO DC DE FL GA IA IL IN KS KY LA MD MI MN MO MS MT NC ND NE NM OH OK PA PR SC SD TN TX UT VA VI WI WV WY
- Contractor site
- www.cgsmedicare.com/jc
Jurisdictions
Contract numbers identify the jurisdiction on remittances and in the Medicare Coverage Database; A and B MAC contracts cover both institutional and professional claims, while DME and HHH contracts are national or regional specialty jurisdictions.
| Contract | Type | States |
|---|---|---|
| 15004 | HHH MAC | CO DC DE IA KS MD MO MT ND NE PA SD UT VA WV WY |
| 15101 | MAC - Part A | KY |
| 15102 | MAC - Part B | KY |
| 15201 | MAC - Part A | OH |
| 15202 | MAC - Part B | OH |
| 17013 | DME MAC | IL IN KY MI MN OH WI |
| 18003 | DME MAC | AL AR CO FL GA LA MS NC NM OK PR SC TN TX VA VI WV |
Most recently effective LCDs
Revision effective dates signal where this contractor has tightened or loosened criteria; the ten newest are listed first, with the full list below.
| LCD | Title | Effective |
|---|---|---|
| L40261 | Peripheral Nerve Injections and Procedures for Chronic Pain | 2026-10-25 |
| L40259 | MolDX: Genetic Testing for Hereditary Thrombophilia | 2026-10-12 |
| L40226 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | 2026-10-12 |
| L40326 | Allergy Diagnostic Testing | 2026-10-04 |
| L34356 | Erythropoiesis Stimulating Agents (ESA) | 2026-10-04 |
| L35442 | MolDX: NRAS Genetic Testing | 2026-09-03 |
| L38771 | Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease | 2026-09-03 |
| L34393 | Ocular Photography - External | 2026-09-03 |
| L34540 | Stretta Procedure | 2026-09-03 |
| L34087 | Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based | 2026-09-03 |
All active LCDs (204)
- L36485 <b> MolDX: HLA-DQB1*06:02 Testing for Narcolepsy</b>
- L40056 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40326 Allergy Diagnostic Testing
- L39434 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39575 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L33686 Ankle-Foot/Knee-Ankle-Foot Orthosis
- L39840 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L40224 Automated Detection and Quantification of Brain MRIs
- L33690 Automatic External Defibrillators
- L33943 B-type Natriuretic Peptide (BNP) Testing
- L36975 Bladder/Urothelial Tumor Markers
- L33944 Blepharoplasty
- L36460 Bone Mass Measurement
- L39857 Botulinum Toxin Injections
- L36267 Bowel Management Devices
- L33950 Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
- L33733 Canes and Crutches
- L33946 Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy
- L33959 Cardiac Catheterization and Coronary Angiography
- L33947 Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
- L33960 Cardiovascular Nuclear Medicine
- L33954 Cataract Extraction
- L33945 Cerumen (Earwax) Removal
- L39741 Cervical Fusion
- L33823 Cervical Traction Devices
- L37254 Chiropractic Services
- L37126 Coenzyme Q10 (CoQ10)
- L33735 Cold Therapy
- L38777 Colon Capsule Endoscopy (CCE)
- L34005 Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
- L33736 Commodes
- L38694 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L34008 Computerized Corneal Topography
- L33999 Corneal Pachymetry
- L39506 Cosmetic and Reconstructive Surgery
- L37598 Cystatin C Measurement
- L34032 Debridement Services
- L34062 Dialysis Access Maintenance
- L38992 Electroretinography (ERG)
- L34081 Endoscopy by Capsule
- L38955 Enteral Nutrition
- L39015 Epidural Steroid Injections for Pain Management
- L34356 Erythropoiesis Stimulating Agents (ESA)
- L33317 External Breast Prostheses
- L33794 External Infusion Pumps
- L39591 External Upper Limb Tremor Stimulator Therapy
- L33737 Eye Prostheses
- L38773 Facet Joint Interventions for Pain Management
- L33738 Facial Prostheses
- L34037 Flow Cytometry
- L38378 Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
- L37575 Frequency of Hemodialysis
- L33822 Glucose Monitors
- L36906 GlycoMark® Testing for Glycemic Control
- L33784 Heating Pads and Heat Lamps
- L33785 High Frequency Chest Wall Oscillation Devices
- L34538 Hospice Determining Terminal Status
- L33820 Hospital Beds And Accessories
- L38307 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38268 Immune Thrombocytopenia (ITP) Therapy
- L33824 Immunosuppressive Drugs
- L38662 Implantable Continuous Glucose Monitors (I-CGM)
- L33825 Infrared Heating Pad Systems
- L39958 Intervertebral Disc Repair
- L33786 Intrapulmonary Percussive Ventilation System
- L33610 Intravenous Immune Globulin
- L35891 Intravenous Immune Globulin
- L33318 Knee Orthoses
- L34090 Laser Ablation of the Prostate
- L33787 Lower Limb Prostheses
- L37608 MDS FISH
- L33788 Manual Wheelchair Bases
- L33795 Mechanical In-exsufflation Devices
- L37578 Micro-Invasive Glaucoma Surgery (MIGS)
- L39802 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L34195 Mohs Micrographic Surgery
- L40199 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L36139 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L38249 MolDX: Blood Product Molecular Antigen Typing
- L36425 MolDX: Breast Cancer Assay: Prosigna®
- L37832 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37130 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37356 MolDX: EndoPredict Breast Cancer Gene Expression Test
- L37905 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L39648 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L40259 MolDX: Genetic Testing for Hereditary Thrombophilia
- L39938 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L35984 MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L37903 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L39017 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L36113 MolDX: MGMT Promoter Methylation Analysis
- L38016 MolDX: Melanoma Risk Stratification Molecular Testing
- L38822 MolDX: Minimal Residual Disease Testing for Cancer
- L39389 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39585 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39427 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39658 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L38997 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L36021 MolDX: Molecular Diagnostic Tests (MDT)
- L39038 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39276 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39940 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39650 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L40140 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L35442 MolDX: NRAS Genetic Testing
- L38070 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38067 MolDX: Next-Generation Sequencing for Solid Tumors
- L40226 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40000 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L36951 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L38394 MolDX: Pharmacogenomics Testing
- L38584 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38111 MolDX: Pigmented Lesion Assay
- L38065 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38284 MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer
- L38586 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L37352 MolDX: Prometheus IBD sgi Diagnostic® Policy
- L38303 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38288 MolDX: Repeat Germline Testing
- L34171 Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation
- L33370 Nebulizers
- L33821 Negative Pressure Wound Therapy Pumps
- L35249 Nerve Blocks for Peripheral Neuropathy
- L35897 Nerve Conduction Studies and Electromyography
- L38771 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L34045 Non-Invasive Vascular Studies
- L34393 Ocular Photography - External
- L38920 Off-label Use of Rituximab and Rituximab Biosimilars
- L34175 Ophthalmic Angiography (Fluorescein and Indocyanine Green)
- L34181 Ophthalmic Biometry for Intraocular Lens Power Calculation
- L34399 Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
- L33826 Oral Anticancer Drugs
- L33827 Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics)
- L33611 Oral Appliances for Obstructive Sleep Apnea
- L33641 Orthopedic Footwear
- L33796 Osteogenesis Stimulators
- L33828 Ostomy Supplies
- L34049 Outpatient Physical and Occupational Therapy Services
- L34353 Outpatient Psychiatry and Psychology Services
- L33797 Oxygen and Oxygen Equipment
- L34064 Panretinal (Scatter) Laser Photocoagulation
- L38953 Parenteral Nutrition
- L33799 Patient Lifts
- L38201 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L40261 Peripheral Nerve Injections and Procedures for Chronic Pain
- L33942 Physical Therapy - Home Health
- L39023 Platelet Rich Plasma Injections for Non-Wound Injections
- L36902 Polysomnography and Other Sleep Studies
- L33718 Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea
- L39521 Positron Emission Tomography (PET) Scan for Inflammation and Infection
- L34085 Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
- L33789 Power Mobility Devices
- L33830 Pressure Reducing Support Surfaces - Group 1
- L33642 Pressure Reducing Support Surfaces - Group 2
- L33692 Pressure Reducing Support Surfaces - Group 3
- L36675 ProMark® Risk Score
- L39284 Prostate Cancer Detection with IsoPSA®
- L36658 Proton Beam Therapy
- L34183 Psychiatric Inpatient Hospitalization
- L34196 Psychiatric Partial Hospitalization Programs
- L34539 Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
- L34063 RAST Type Tests
- L33793 Refractive Lenses
- L34200 Removal of Benign Skin Lesions
- L33800 Respiratory Assist Devices
- L34246 Routine Foot Care and Debridement of Nails
- L39383 Sacroiliac Joint Injections and Procedures
- L34061 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L33801 Seat Lift Mechanisms
- L35906 Somatosensory Testing
- L35986 Special Histochemical Stains and Immunohistochemical Stains
- L33739 Speech Generating Devices (SGD)
- L34046 Speech-Language Pathology
- L33790 Spinal Orthoses: TLSO and LSO
- L34540 Stretta Procedure
- L33612 Suction Pumps
- L40179 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L33831 Surgical Dressings
- L34087 Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
- L40244 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L33369 Therapeutic Shoes for Persons with Diabetes
- L40232 Total Joint Arthroplasty
- L33832 Tracheostomy Care Supplies
- L34084 Transcatheter Infusion Therapy
- L36469 Transcranial Magnetic Stimulation (TMS)
- L34821 Transcutaneous Electrical Joint Stimulation Devices (TEJSD)
- L33802 Transcutaneous Electrical Nerve Stimulators (TENS)
- L34337 Transesophageal Echocardiography (TEE)
- L34541 Transtelephonic Spirometry
- L34338 Transthoracic Echocardiography (TTE)
- L39656 Trigger Point Injections (TPI)
- L34823 Tumor Treatment Field Therapy (TTFT)
- L39616 Urinary Biomarkers for Chronic Pain Management
- L36029 Urine Drug Testing
- L34056 Urodynamics
- L33803 Urological Supplies
- L34824 Vacuum Erection Devices (VED)
- L34082 Varicose Veins of the Lower Extremity, Treatment of
- L34394 Visual Fields Testing
- L33996 Vitamin D Assay Testing
- L33791 Walkers
- L33792 Wheelchair Options/Accessories
- L33312 Wheelchair Seating
- L36690 Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
How to use this contractor's policies
A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so the first question is which jurisdiction the rendering location falls in; the contracts table above answers that for institutional and professional claims, and durable medical equipment follows the DME MAC region instead. Each LCD states the covered indications, the documentation the record must contain and, through its companion Billing and Coding Article, the ICD-10 codes that support medical necessity and the HCPCS codes the policy edits. When a claim denies with CARC 50 and remark N115, the remark names the LCD; open it from the list above, compare the diagnosis on the claim with the article's covered list, and build the appeal on the documentation requirements rather than on the policy itself. Where this contractor has no LCD for a service and no National Coverage Determination exists, coverage is decided claim by claim under the reasonable-and-necessary standard, which is where prior authorization and pre-service review earn their keep.
Frequently asked questions
Which states does CGS Administrators, LLC cover?
CGS Administrators, LLC holds 7 Medicare contracts (15004 HHH MAC; 15101 MAC - Part A; 15102 MAC - Part B; 15201 MAC - Part A; 15202 MAC - Part B; 17013 DME MAC; 18003 DME MAC) covering AL, AR, CO, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NM, OH, OK, PA, PR, SC, SD, TN, TX, UT, VA, VI, WI, WV, WY.
How many LCDs does CGS Administrators, LLC have?
204 Local Coverage Determinations are active in the current Medicare Coverage Database export for CGS Administrators, LLC. Each LCD applies only in that contractor's jurisdiction, so the same service can be covered differently in a neighbouring state.
What is the difference between an LCD and an NCD?
A National Coverage Determination is set by CMS and binds every contractor. A Local Coverage Determination is written by one Medicare Administrative Contractor for its jurisdiction and cannot conflict with an NCD; where no NCD exists, the LCD is the controlling policy.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-09-24 · effective 2026-09-20 · file lcd.csvSHA-256 2fcc4251b6ddd1eb…
Disclaimer
Contractor jurisdictions and LCD lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify coverage against the current LCD text on cms.gov or the contractor site before billing. Not legal, clinical or billing advice.